WESTERN COUNTERPARTS

Dr Reddy’s, Bayer join hands to roll out 2nd brand of heart failure drug Vericiguat in India

Vericiguat, a soluble guanylate cyclase (sGC) stimulator, in India, is indicated, along with guideline-based medical therapy, in adults with symptomatic chronic heart failure with reduced ejection fraction (less than 45%), following a recent event of worsening heart failure which required hospitalization or outpatient intravenous (IV) diuretics.